| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |